Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sumatriptan for cilostazol-induced headache in healthy volunteers
NCT03156920Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- May 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of sumatriptan in migraine, sponsored by Dansk Hovedpinecenter. Primary endpoints: Median headache score 2 hours after cilostazol and Area under the headache score curve at 12 hours. Started May 2017; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT03156920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156920.